
Summary:
In this podcast, recorded at the 2024 Patients as Partners Europe conference, GSK and Ovacome present how they developed a unique, mutually beneficial partnership that allowed GSK to explore the entire patient experience when living with a disease in a real-world setting, and gain insights from patient organizations to drive actionable change within clinical research. The Ovacome-GSK partnership impacted the full product lifecycle, by focusing on the entire patient experience, not just the narrow amount of time they're eligible for a trial.
This presentation covers the impact of a pharma-patient organization partnership on:
- Patient Engagement Tools
- Addressing Health Inequality within the patient community
- Real-world evidence generation
Related Podcasts
View All
Tufts Center for Study of Drug Development on Evolving Clinical Trial Partnerships

Boehringer Ingelheim on Collaborations in Clinical Development for Launch Readiness

How Roche Maximizes the Impact of Patient Insights in Early Development for a Blueprint to De-Risk Molecule Development
